A. Enk

1.5k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

A. Enk is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, A. Enk has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in A. Enk's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (3 papers). A. Enk is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (3 papers). A. Enk collaborates with scholars based in Germany. A. Enk's co-authors include Jürgen Knop, Helmut Jonuleit, Kerstin Steinbrink, Matthias Wölfl, Gabriele Müller, J. Knop, Gerold Schuler, Tieno Germann, Joachim Saloga and Antonia Dimitrakopoulou‐Strauss and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

A. Enk

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of tolerance by IL-10-treated dendritic cells

1997 1.0k citations Kerstin Steinbrink, Matthias Wölfl et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Enk Germany	8	1.1k	238	178	109	65	13	1.3k
Thierry Sornasse United States	12	1.1k 1.0×	254 1.1×	210 1.2×	96 0.9×	56 0.9×	30	1.4k
Daniela Reider Austria	7	1.1k 1.1×	229 1.0×	353 2.0×	73 0.7×	77 1.2×	11	1.4k
Javier Vega‐Ramos Australia	15	1.3k 1.2×	276 1.2×	200 1.1×	77 0.7×	61 0.9×	19	1.5k
Toshimichi Matsui Japan	11	660 0.6×	200 0.8×	220 1.2×	43 0.4×	44 0.7×	15	958
P Ferrara France	12	726 0.7×	179 0.8×	121 0.7×	49 0.4×	117 1.8×	20	955
Caroline Dubey United States	13	1.1k 1.0×	187 0.8×	163 0.9×	37 0.3×	115 1.8×	15	1.3k
Uwe Niesner Germany	8	813 0.7×	171 0.7×	236 1.3×	41 0.4×	62 1.0×	9	1.2k
Olivia Perng United States	6	944 0.9×	182 0.8×	97 0.5×	37 0.3×	66 1.0×	9	1.1k
Christiane Siewert Germany	9	1.9k 1.8×	327 1.4×	299 1.7×	64 0.6×	93 1.4×	14	2.2k
Jan D. Haas Germany	10	903 0.8×	107 0.4×	96 0.5×	164 1.5×	43 0.7×	10	1.1k

Countries citing papers authored by A. Enk

Since Specialization

Citations

This map shows the geographic impact of A. Enk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Enk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Enk more than expected).

Fields of papers citing papers by A. Enk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Enk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Enk. The network helps show where A. Enk may publish in the future.

Co-authorship network of co-authors of A. Enk

This figure shows the co-authorship network connecting the top 25 collaborators of A. Enk. A scholar is included among the top collaborators of A. Enk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Enk. A. Enk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Lang, Nina, Alla Slynko, Annette Kopp‐Schneider, et al.. (2016). Use of LDH and Autoimmune Side Effects to Predict Response to Ipilimumab Treatment. Immunotherapy. 8(9). 1033–1044. 43 indexed citations

2.

Möhr, Peter, Axel Hauschild, A. Enk, et al.. (2008). Intermittent high-dose intravenous interferon alpha 2b (IFNa2b) for adjuvant treatment of stage III malignant melanoma: An interim analysis of a randomized phase III study (NCT00226408). Journal of Clinical Oncology. 26(15_suppl). 9040–9040. 2 indexed citations

3.

Mohr, Peter, Axel Hauschild, Uwe Trefzer, et al.. (2007). Health-related quality of life measures in melanoma patients receiving pulsed high-dose intravenous interferon alpha 2b (IFNα2b). Journal of Clinical Oncology. 25(18_suppl). 8536–8536. 1 indexed citations

4.

Enk, A.. (2006). DCs and Cytokines Cooperate for the Induction of Tregs. PubMed. 97–106. 11 indexed citations

5.

Schadendorf, Dirk, Frank O. Nestlé, A. Enk, et al.. (2004). Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study. Journal of Clinical Oncology. 22(14_suppl). 7508–7508. 11 indexed citations

6.

Schadendorf, Dirk, Frank O. Nestlé, A. Enk, et al.. (2004). Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study. Journal of Clinical Oncology. 22(14_suppl). 7508–7508. 3 indexed citations

7.

Müller, Gabriele, et al.. (2000). Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. Gene Therapy. 7(12). 1000–1004. 36 indexed citations

8.

Enk, A., G M Mueller, Helmut Jonuleit, et al.. (1999). Prophylaxis and therapy of ongoing immune responses by IL-10-treated dendritic cells in vivo. Journal of Investigative Dermatology. 112(4). 523. 1 indexed citations

9.

Steinbrink, Kerstin, Helmut Jonuleit, Gabriele Müller, J. Knop, & A. Enk. (1998). IL-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Journal of Dermatological Science. 16. S7–S7. 8 indexed citations

10.

Steinbrink, Kerstin, Matthias Wölfl, Helmut Jonuleit, Jürgen Knop, & A. Enk. (1997). Induction of tolerance by IL-10-treated dendritic cells. The Journal of Immunology. 159(10). 4772–4780. 1029 indexed citations breakdown →

11.

Müller, Gabriele, Joachim Saloga, Tieno Germann, et al.. (1995). IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. The Journal of Immunology. 155(10). 4661–4668. 112 indexed citations

12.

Vogel, Jonathan, et al.. (1995). THE HIV TAT GENE IS A PROMOTER OF EPIDERMAL SKIN TUMORS. International Journal of Oncology. 7(4). 727–33. 9 indexed citations

13.

Enk, A., George W. Muller, Joachim Saloga, et al.. (1994). Human keratinocyte-derived interleukin-12 affects LC-induced primary T-cell responses. Journal of Investigative Dermatology. 103(3). 429. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact